The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI) today announced a major collaboration focused on neoantigens. The search for these unique cancer markers has become a robust area of research as scientists believe they may hold the key to developing a new generation of personalized, targeted cancer immunotherapies.
Parker Institute for Cancer Immunotherapy and Cancer Research Institute Launch Collaboration on Cancer Neoantigens
My Health eNews
- Choose the news you want from more than two dozen topics.
- Medically-reviewed health news drawn from 350+ sources, delivered monthly to your inbox.
- Your username and password ensure your personalized news is delivered only to you.